Carlat Psychiatry(@CarlatPsych) 's Twitter Profileg
Carlat Psychiatry

@CarlatPsych

Founded and Published by Daniel Carlat, MD. Unbiased since 2003. Subscribe: https://t.co/makW8HKzi2 #psychtwitter

ID:21500995

linkhttp://www.thecarlatreport.com calendar_today21-02-2009 17:27:34

2,8K Tweets

7,3K Followers

4,7K Following

Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

1st lumateperone (Caplyta) RCT in major :
> Aug , medium effect size (0.6)
> 6 wks, 485 pts, 1-2 failed med trials
> Fatigue, dry mouth, tremor main side effects

Data unpublished, summary here:
ir.intracellulartherapies.com/news-releases/…

2nd trial anticipated in summer.

1st lumateperone (Caplyta) RCT in major #depression: > Aug #antidepressants, medium effect size (0.6) > 6 wks, 485 pts, 1-2 failed med trials > Fatigue, dry mouth, tremor main side effects Data unpublished, summary here: ir.intracellulartherapies.com/news-releases/… 2nd trial anticipated in summer.
account_circle
Carlat Psychiatry(@CarlatPsych) 's Twitter Profile Photo

A popular DIY (home-based) therapy for depression (transcranial direct current stimulation) is tested in ADHD thecarlatreport.com/articles/4665-…

account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

PEA improved post-COVID olfaction in 6 RCTs, and lifted post-COVID depression/fatigue in new comparative trial (small, not randomized)
pubmed.ncbi.nlm.nih.gov/38381905

It has small RCTs in , mania, , .

Learn how to use it:
moodtreatmentcenter.com/products

PEA improved post-COVID olfaction in 6 RCTs, and lifted post-COVID depression/fatigue in new comparative trial (small, not randomized) pubmed.ncbi.nlm.nih.gov/38381905 It has small RCTs in #depression, #bipolar mania, #migraine, #pain. Learn how to use it: moodtreatmentcenter.com/products
account_circle
Carlat Psychiatry(@CarlatPsych) 's Twitter Profile Photo

We need a little help in figuring out if [our kids are] simply developing at a slower pace, or if they could be showing signs of autism Positive Development positivedevelopment.com/blogs/top-sign…

account_circle
Carlat Psychiatry(@CarlatPsych) 's Twitter Profile Photo

New podcast with Joshua D Feder and Mara Goverman, LCSW: What steps should clinicians take if psychopharmacologic treatments and school behavioral strategies are insufficient for managing ADHD in children? Learn more about the ADHD Algorithm at thecarlatreport.com/blogs/2-the-ca…

New podcast with @jdfeder and Mara Goverman, LCSW: What steps should clinicians take if psychopharmacologic treatments and school behavioral strategies are insufficient for managing ADHD in children? Learn more about the ADHD Algorithm at thecarlatreport.com/blogs/2-the-ca…
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Silexan (lavender extract approved for anxiety in Europe) is more effective than SSRIs in head-to-head trials & worked better for more severe in new analysis of 5 RCTs:
pubmed.ncbi.nlm.nih.gov/38425206

Podcast:
thecarlatreport.com/blogs/2-the-ca…

How to use:
moodtreatmentcenter.com/products

Silexan (lavender extract approved for anxiety in Europe) is more effective than SSRIs in head-to-head trials & worked better for more severe #anxiety in new analysis of 5 RCTs: pubmed.ncbi.nlm.nih.gov/38425206 Podcast: thecarlatreport.com/blogs/2-the-ca… How to use: moodtreatmentcenter.com/products
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

First case of ketamine tolerance from Mayo Clinic:
pubmed.ncbi.nlm.nih.gov/38597410

To stay well, the patient required increasing frequency of , until it no longer worked after 5 years.

First case of ketamine tolerance from Mayo Clinic: pubmed.ncbi.nlm.nih.gov/38597410 To stay well, the patient required increasing frequency of #ketamine, until it no longer worked after 5 years. #depression #psychiatry
account_circle
Carlat Psychiatry(@CarlatPsych) 's Twitter Profile Photo

Incarcerated individuals with opioid use disorder are at an especially heightened risk of adverse outcomes.  The period immediately following release is a particularly vulnerable time, with an elevated risk of fatal overdose. thecarlatreport.com/articles/4617-…

account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Two psych meds held promise for : lithium and fluvoxamine, an antidepressant. So far, the data favors :
ncbi.nlm.nih.gov/pmc/articles/P…

but not the SSRI:
pubmed.ncbi.nlm.nih.gov/37002592

Two psych meds held promise for #COVID: lithium and fluvoxamine, an #SSRI antidepressant. So far, the data favors #lithium: ncbi.nlm.nih.gov/pmc/articles/P… but not the SSRI: pubmed.ncbi.nlm.nih.gov/37002592 #psychiatry
account_circle
Carlat Psychiatry(@CarlatPsych) 's Twitter Profile Photo

'Psychopathological phenomena don’t always indicate complete dysfunction. Similar to issues in general medicine, mental health problems involve a mix of function and dysfunction' -Awais Aftab. Our EIC Mark L. Ruffalo speaks with Dr. Aftab. Enjoy! thecarlatreport.com/articles/4674-…

account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Update on :
1. Large effect in assisted therapy (full remission in 61-71%)
2. Preliminary trials in , social , use disorder
3. All trials from the same company (Lykos/MAPS)

From a review by Owen Scottt Muir, MD, DFAACAP et al:
pubmed.ncbi.nlm.nih.gov/38518271

Update on #MDMA: 1. Large effect in #PTSD assisted therapy (full remission in 61-71%) 2. Preliminary trials in #autism, social #anxiety, #alcohol use disorder 3. All trials from the same company (Lykos/MAPS) From a review by @ScottMuirMD et al: pubmed.ncbi.nlm.nih.gov/38518271
account_circle
Carlat Psychiatry(@CarlatPsych) 's Twitter Profile Photo

What do you look for to diagnose Fetal Alcohol Spectrum Disorder (FASD)? Dr. Ira Chasnoff describes the broad impact of FASD and what to look for in the patient’s history (hint: you usually won’t see facial stigmata). thecarlatreport.com/articles/4648-…

What do you look for to diagnose Fetal Alcohol Spectrum Disorder (FASD)? Dr. Ira Chasnoff describes the broad impact of FASD and what to look for in the patient’s history (hint: you usually won’t see facial stigmata). #psychiatry #mentalhealth thecarlatreport.com/articles/4648-…
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Curcumin & omega3 improve , (DM).

New trial tested them in DM: benefits in some but not all metabolic markers. Not clear if passes corrections for multiple measures.
pubmed.ncbi.nlm.nih.gov/38589346

Learn how to use them in depression
moodtreatmentcenter.com/products

Curcumin & omega3 improve #depression, #diabetes (DM). New trial tested them in DM: benefits in some but not all metabolic markers. Not clear if passes corrections for multiple measures. pubmed.ncbi.nlm.nih.gov/38589346 Learn how to use them in depression moodtreatmentcenter.com/products
account_circle
Mark L. Ruffalo(@MarkLRuffalo) 's Twitter Profile Photo

Borderline patients in the 'vindictive problem pattern' self-reported lower functional disturbances, though they remained significantly clinically impaired. In other words, vindictive borderline patients underestimate the severity of their impairment.

Borderline patients in the 'vindictive problem pattern' self-reported lower functional disturbances, though they remained significantly clinically impaired. In other words, vindictive borderline patients underestimate the severity of their impairment.
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

N-acetylcysteine (NAC, 2400 mg/d) reduced in a small randomized trial:
pubmed.ncbi.nlm.nih.gov/38500894

The antioxidant has mixed results in substance/mood disorders. It prevented renal toxicity in animal studies. Learn how to use it:
moodtreatmentcenter.com/products

N-acetylcysteine (NAC, 2400 mg/d) reduced #nicotine #smoking in a small randomized trial: pubmed.ncbi.nlm.nih.gov/38500894 The antioxidant has mixed results in substance/mood disorders. It prevented #lithium renal toxicity in animal studies. Learn how to use it: moodtreatmentcenter.com/products
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

FDA cleared Rejoin, 1st app for , based on a large trial that failed on primary outcome but was positive on secondary outcomes:
rejoynhcp.com/Clinician-Brie…

Combines w/ emotional training game designed to improve recognition of facial expressions. Release = Summer '24

FDA cleared Rejoin, 1st app for #depression, based on a large trial that failed on primary outcome but was positive on secondary outcomes: rejoynhcp.com/Clinician-Brie… Combines #CBT w/ emotional training game designed to improve recognition of facial expressions. Release = Summer '24
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

What's the future for use disorder?

Besides FDA-approved ones below, review finds varying support for baclofen, ondansetron, gabapentin, topiramate, , ibudilast, GLP-1 agonists, GHB, and TMS:
ncbi.nlm.nih.gov/pmc/articles/P…

life

What's the future for #alcohol use disorder? Besides FDA-approved ones below, review finds varying support for baclofen, ondansetron, gabapentin, topiramate, #psychedelic #therapy, ibudilast, GLP-1 agonists, GHB, and TMS: ncbi.nlm.nih.gov/pmc/articles/P… #sober #soberlife #recovery
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

New for use d/o: Cyproheptadine+Prazosin. The combo reduced drinking in RCT of 154 (3 mth, medium effect)
pubmed.ncbi.nlm.nih.gov/38597214

Cyproheptadine is similar to mirtazapine and has small trials various psych disorders. Prazosin a blood pressure medicine used in .

New for #alcohol use d/o: Cyproheptadine+Prazosin. The combo reduced drinking in RCT of 154 (3 mth, medium effect) pubmed.ncbi.nlm.nih.gov/38597214 Cyproheptadine is similar to mirtazapine and has small trials various psych disorders. Prazosin a blood pressure medicine used in #PTSD.
account_circle
Chris Aiken, MD(@chrisaikenmd) 's Twitter Profile Photo

Updates on :
1. Impressive preliminary results: in UD; in
2. Enduring benefits in some trials
3. Low drop out rates
4. High dose, chronic or recreational use = dangerous

From new review:
pubmed.ncbi.nlm.nih.gov/38518271

Art: Roger Dean

Updates on #psychedelics: 1. Impressive preliminary results: #psilocybin in #Alcohol UD; #DMT in #Depression 2. Enduring benefits in some trials 3. Low drop out rates 4. High dose, chronic or recreational use = dangerous From new review: pubmed.ncbi.nlm.nih.gov/38518271 Art: Roger Dean
account_circle